NEOADJUVANT HIGH-DOSE METHOTREXATE, CISPLATIN, AND DOXORUBICIN FOR THE MANAGEMENT OF PATIENTS WITH NONMETASTIC OSTEOSARCOMA

被引：0
|
作者：
WEINER, MA
HARRIS, MB
LEWIS, M
JONES, R
SHERRY, H
FEURER, EJ
JOHNSON, J
LAHMAN, E
机构：
[1] MT SINAI MED CTR,DEPT NEOPLAST DIS,NEW YORK,NY 10029
[2] MT SINAI MED CTR,DEPT ORTHOPED,NEW YORK,NY 10029
[3] MT SINAI MED CTR,DEPT BIOMATH SCI,NEW YORK,NY 10029
[4] HOSP JOINT DIS,INST ORTHOPED,BONE TUMOR SERV,NEW YORK,NY 10003
来源：
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1431 / 1432
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity:: A joint study by the Italian and Scandinavian Sarcoma Groups
    Ferrari, S
    Smeland, S
    Mercuri, M
    Bertoni, F
    Longhi, A
    Ruggieri, P
    Alvegard, TA
    Picci, P
    Capanna, R
    Bernini, G
    Müller, C
    Tienghi, A
    Wiebe, T
    Comandone, A
    Böhling, T
    Del Prever, AB
    Brosjö, O
    Bacci, G
    Sæter, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8845 - 8852
  • [2] Neoadjuvant chemotherapy with high-dose methotrexate in osteosarcoma
    Mir, Olivier
    Ropert, Stanislas
    Goldwasser, Francois
    LANCET ONCOLOGY, 2008, 9 (12): : 1198 - 1198
  • [3] Neoadjuvant chemotherapy with high-dose ifosfamide, doxorubicin and cisplatin in nonmetastatic osteosarcoma of the extremity.
    Kudawara, I
    Leguchi, M
    Aoki, Y
    Naka, N
    Araki, N
    Nakanishi, H
    Matsumine, A
    Myoui, A
    Ueda, T
    Yoshikawa, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 827S - 827S
  • [4] Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan
    Kudawara, Ikuo
    Aoki, Yasuaki
    Ueda, Takafumi
    Araki, Nobuhito
    Naka, Norifumi
    Nakanishi, Hirofumi
    Matsumine, Akihiko
    Ieguchi, Makoto
    Mori, Shigeki
    Myoui, Akira
    Kuratsu, Shigeyuki
    Hashimoto, Nobuyuki
    Yoshikawa, Hideki
    JOURNAL OF CHEMOTHERAPY, 2013, 25 (01) : 41 - 48
  • [5] Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate
    Meyers, PA
    Schwartz, CL
    Krailo, M
    Kleinerman, ES
    Betcher, D
    Bernstein, ML
    Conrad, E
    Ferguson, W
    Gebhardt, M
    Goorin, AM
    Harris, MB
    Healey, J
    Huvos, A
    Link, M
    Montebello, J
    Nadel, H
    Nieder, M
    Sato, J
    Siegal, G
    Weiner, M
    Wells, R
    Wold, L
    Womer, R
    Grier, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) : 2004 - 2011
  • [6] A prospective, multicentre trial of high-dose methotrexate/doxorubicin or cisplatin/doxorubicin for children and young adults with osteosarcoma - decision making analysisb
    Wozniak, W.
    Chybicka, A.
    Kowalczyk, J.
    Wysocki, M.
    Korzon, M.
    Krawczuk-Rybak, M.
    Rychlowska-Pruszynska, M.
    Szamotulska, K.
    Lugowska, I.
    EJC SUPPLEMENTS, 2009, 7 (02): : 224 - 224
  • [7] Perioperative chemotherapy with cisplatin (CP) and doxorubicin (DOX) with and without high-dose methotrexate (HDM) in adult osteosarcoma (AOT): Is methotrexate warranted?
    Da Silva Rocha, Lucila Soares
    Negrao, Marcelo Vailati
    Girardi, Daniel da Motta
    De Camargo, Veridiana Pires
    Valente Alban, Luciana Bastos
    Hoff, Paulo Marcelo
    Feher, Olavo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Clinical analysis of osteosarcoma patients treated with high-dose methotrexate-free neoadjuvant chemotherapy
    Xu, M.
    Xu, F.
    Yu, C.
    CURRENT ONCOLOGY, 2014, 21 (05) : E678 - E684
  • [9] High-dose methotrexate in fibroblastic osteosarcoma
    Chowbay, B
    Siong, KK
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (12) : 1669 - 1669
  • [10] SFOPOS94:: A randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients
    Le Deley, Marie-Cecile
    Guinebretiere, Jean-Marc
    Gentet, Jean-Claude
    Pacquement, Helene
    Pichon, Fabienne
    Marec-Berard, Perrine
    Entz-Werle, Natacha
    Schmitt, Claudine
    Brugieres, Laurence
    Vanel, Daniel
    Dupouy, Noelle
    Tabone, Marie-Dominique
    Kalifa, Chantal
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (04) : 752 - 761
12345